Skip to content

Research on the standardized collection of empirical data and the formation of high-quality evidence for the treatment of hemorrhoids patients with Huaizhi mixture

Research on the standardized collection of empirical data and the formation of high-quality evidence for the treatment of hemorrhoids patients with Huaizhi mixture

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001811
Enrollment
Unknown
Registered
2025-09-24
Start date
2025-10-01
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

mixed hemorrhoid

Interventions

Control Group :Starting from the day after surgery the patient will be given oral placebo three times a day 20 ml each time for a course of one week.
Experimental group :Starting from the day after surgery the patient will be given oral Huaizhi mixture three times a day 20 ml each time for a course of one week.

Sponsors

Chongqing Traditional Chinese Medicine Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Only those who meet all of the following conditions can be included: 1.18 years old = age = 75 years old; 2. Meet the normative requirements of the established dual diagnostic criteria of traditional Chinese medicine and Western medicine mentioned above; 3. Hemorrhoids are mainly distributed in the primary sites at 3 7 and 11 points; 4. All patients underwent mixed hemorrhoid external dissection and internal ligation surgery; 5. No severe central nervous system liver or kidney diseases and no organic changes in other important organs; 6. Postoperative vital signs are stable and can actively cooperate with subsequent treatment; 7. The patient voluntarily participates in the trial and signs an informed consent form.

Exclusion criteria

Exclusion criteria: Any of the following conditions are excluded: 1. History of heart disease coagulation disease and anticoagulant therapy; 2. Individuals with serious primary diseases such as colorectal or anal tumors inflammatory bowel disease etc; 3. Other anal and rectal diseases (anal fistula and fissure) etc; 4.Previous history of anal surgery sclerotherapy or rubber band ligation; 5.Pregnant and lactating women; 6.Participants in other clinical trials. 7. Due to other reasons it may not be possible to complete this study or the researcher may consider it unsuitable to participate in the trial.

Design outcomes

Primary

MeasureTime frame
hematochezia;

Secondary

MeasureTime frame
constipation;Anal margin edema;Itching/discharge;

Countries

China

Contacts

Public ContactYue Xu

Chongqing Traditional Chinese Medicine Hospital

827093411@qq.com13627661756

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026